Quantum BioPharma Ltd. (QNTM)
NASDAQ: QNTM · Real-Time Price · USD
22.51
+0.05 (0.22%)
At close: Jul 17, 2025, 4:00 PM
22.07
-0.44 (-1.95%)
After-hours: Jul 17, 2025, 6:08 PM EDT
Quantum BioPharma Employees
Quantum BioPharma had 17 employees as of December 31, 2022. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
n/a
Profits / Employee
-$1,228,004
Market Cap
76.10M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 17 | 7 | 70.00% |
Dec 31, 2021 | 10 | 1 | 11.11% |
Dec 31, 2020 | 9 | -9 | -50.00% |
Dec 31, 2019 | 18 | -1 | -5.26% |
Dec 31, 2018 | 19 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
QNTM News
- 20 days ago - Quantum BioPharma Announces Private Placement - GlobeNewsWire
- 21 days ago - Quantum BioPharma Licensee Unbuzzd Wellness Inc. Launches $5 Million Reg D Capital Raise to Fund Growth and Path to Possible Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Singular Research Reports on Quantum BioPharma Ltd.'s Strategic Advances and Pipeline Progress - Newsfile Corp
- 4 weeks ago - Quantum BioPharma Announces First Person with Multiple Sclerosis (MS) Scanned in Joint Study with Massachusetts General Hospital - GlobeNewsWire
- 4 weeks ago - Quantum BioPharma Announces Intention to Declare Special Dividend of Contingent Value Rights (CVRs) Linked to Future Litigation Settlement Proceeds - GlobeNewsWire
- 6 weeks ago - Quantum BioPharma Clarifies It Has Not Changed Its Name - GlobeNewsWire
- 6 weeks ago - iNGENū CRO Partners with Quantum BioPharma to Launch Pioneering Australian Clinical Trial for Chronic Nociplastic Pain in MCAS Patients - GlobeNewsWire
- 6 weeks ago - Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari - GlobeNewsWire